DE691339C - Process for the preparation of concentrated aqueous theophylline solutions - Google Patents
Process for the preparation of concentrated aqueous theophylline solutionsInfo
- Publication number
- DE691339C DE691339C DE1939C0054812 DEC0054812D DE691339C DE 691339 C DE691339 C DE 691339C DE 1939C0054812 DE1939C0054812 DE 1939C0054812 DE C0054812 D DEC0054812 D DE C0054812D DE 691339 C DE691339 C DE 691339C
- Authority
- DE
- Germany
- Prior art keywords
- theophylline
- preparation
- concentrated aqueous
- ephedrine
- solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von konzentrierten wäßrigen Theophyllinlösungen Zusatz zum Patent 690 488 Es sind bereits verschiedene Verfahren bekannt, um das schwer lösliche Theophyllin in wäßrige Lösungen zu überführen. Hierbei hat man als Lösungsvermittler leicht wasserlös- -liche Amine, wie Äthylendiamin oder Diäthanolamin, verwendet.Process for the preparation of concentrated aqueous theophylline solutions Addendum to Patent 690 488 Various methods are already known for the To convert poorly soluble theophylline into aqueous solutions. Here you have as Solubilizers readily water-soluble amines, such as ethylenediamine or diethanolamine, used.
Gegenstand des Hauptpatents ist ein Verfahren zur Herstellung . von konzentrierten wäßrigen Koffeinlösungen unter Anwendung von ß-Phenylisopropylamin oder seiner Derivate mit ephedrinartiger Wirkung, wie Ephedin, Ph enylmethylaminopropanol (synthetisches, razemisches Ephedrin) oder ihren Salzen, als Lösungsvermittler. The main patent relates to a method of manufacture. from concentrated aqueous caffeine solutions using ß-phenylisopropylamine or its derivatives with an ephedrine-like effect, such as ephedine, phenylmethylaminopropanol (synthetic, racemic ephedrine) or their salts, as solubilizers.
Es wurde nun gefunden, daß man solche Verbindungen auch als Lösungsvermittler für das Theophyllin verwenden kann. Dieses Ergebnis ist durchaus überraschend, da sowohl das Theophyllin als auch die Verbindungen mit ephedrinartiger Wirkung an sich schwer löslich sind. It has now been found that such compounds can also be used as solubilizers for which theophylline can use. This result is quite surprising since both theophylline and the compounds with ephedrine-like effects are difficult to dissolve.
Die Löslichkeit der genannten Stoffe in Wasser von Zimmertemperatur ist die folgende: Theophyllin . . weniger als 1%, Ephedrin ..... . .. .... etwa 4%, Phenylmethylaminopropanol etwa 2,70/0, ß-Phenylisopropylamin weniger als 1,7%. The solubility of the substances mentioned in water at room temperature is the following: theophylline. . less than 1%, ephedrine ...... .. .... approximately 4%, phenylmethylaminopropanol about 2.70 / 0, β-phenylisopropylamine less than 1.7%.
Durch gemeinsames Lösen von Theophyllin und einer dieser Verbindungen können aber Lösungen hergestellt werden, die bis zu I9,8 % Theophyllin und bis zu 33% der ephedrin--artigen Verbindungen enthalten. By dissolving theophylline and one of these compounds together but solutions can be prepared containing up to 19.8% theophylline and up to Contains 33% of ephedrine-like compounds.
Beispiele I. 19,8 g.Theophyllin werden mit 27,0 g ß-Phenylisopropylamin innig vermengt und das Gemenge mit destilliertem Wasserbad 100 ccm aufgefüllt. Die beiden schwer löslichen Verbindungen gehen in völlig klare Lösung über. Der Lösungsvorgang kann gegebenenfalls durch Erwärmen beschleunigt werden. In der Lösung liegen das Theoph l und die ephedrinartige Verbindung in så Verhältnis von 1 Mol zu 1 Mol vor. Examples I. 19.8 g of theophylline are mixed with 27.0 g of β-phenylisopropylamine intimately mixed and the mixture made up with a 100 ccm distilled water bath. the both sparingly soluble Connections go into completely clear solution above. The dissolution process can optionally be accelerated by heating. In the solution, the Theoph I and the ephedrine-like compound are in the same relationship from 1 mole to 1 mole.
2. 19,8 g Theophyllin werden mit Hilfe 16,5 g bzw. 33,0 g Ephedrin gemäß Beispiel ad 100 ccm in wäßrige Lösung übergeführt. 2. 19.8 g of theophylline become with the aid of 16.5 g or 33.0 g of ephedrine According to the example, converted to 100 cc in aqueous solution.
Im ersten Falle liegen Theophyllin und Ephedrin im Verhältnis 1 Mol zu I Mol, im zweiten Falle I Mol zu 2 Mol vor.In the first case, theophylline and ephedrine are in a ratio of 1 mole to I mol, in the second case I mol to 2 mol.
3. 12,4 g Theophyllin werden unter Zusatz von 10 g Phenylmethylaminopropanol ad 100 ccm Wasser in Lösung übergeführt. 3. 12.4 g of theophylline are added with the addition of 10 g of phenylmethylaminopropanol converted into solution ad 100 ccm of water.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1939C0054812 DE691339C (en) | 1939-02-24 | 1939-02-24 | Process for the preparation of concentrated aqueous theophylline solutions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1939C0054812 DE691339C (en) | 1939-02-24 | 1939-02-24 | Process for the preparation of concentrated aqueous theophylline solutions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE691339C true DE691339C (en) | 1940-05-23 |
Family
ID=7028024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1939C0054812 Expired DE691339C (en) | 1939-02-24 | 1939-02-24 | Process for the preparation of concentrated aqueous theophylline solutions |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE691339C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2498687A (en) * | 1945-11-01 | 1950-02-28 | Delmar H Larsen | Vasoconstrictor composition |
DE900486C (en) * | 1942-06-02 | 1953-12-28 | Byk Gulden Lomberg Chem Fab | Process for the production of concentrated, aqueous solutions of theophylline |
US2739921A (en) * | 1951-11-21 | 1956-03-27 | Upjohn Co | Bronchodilator composition of beta-(orthomethoxy phenyl)-isopropylmethylamine with theophylline |
DE944518C (en) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Process for the preparation of solutions of xanthines substituted in the 1,3-position |
-
1939
- 1939-02-24 DE DE1939C0054812 patent/DE691339C/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE900486C (en) * | 1942-06-02 | 1953-12-28 | Byk Gulden Lomberg Chem Fab | Process for the production of concentrated, aqueous solutions of theophylline |
US2498687A (en) * | 1945-11-01 | 1950-02-28 | Delmar H Larsen | Vasoconstrictor composition |
DE944518C (en) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Process for the preparation of solutions of xanthines substituted in the 1,3-position |
US2739921A (en) * | 1951-11-21 | 1956-03-27 | Upjohn Co | Bronchodilator composition of beta-(orthomethoxy phenyl)-isopropylmethylamine with theophylline |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE691339C (en) | Process for the preparation of concentrated aqueous theophylline solutions | |
DE690488C (en) | Process for the production of concentrated aqueous caffeine solutions | |
DE940383C (en) | Herbicides | |
DE709176C (en) | Process for the production of long-life aqueous solutions containing k-strophanthin, theophylline and grape sugar | |
DE681523C (en) | Process for the preparation of quaternary ammonium compounds | |
DE872980C (en) | Process for the production of concentrated aqueous solutions of poorly soluble salts of amino-6-methyl-2-heptens-2 and its N-derivatives | |
DE725923C (en) | Process for the production of concentrated solutions of organic medicinal products which are poorly soluble or insoluble in water | |
DE929092C (en) | Process for the production of polyamide solutions | |
DE812912C (en) | Process for the preparation of a mixture of hexamethylene tetramine rhodanide and ammonium sulfate | |
DE872246C (en) | Production of readily water-soluble compounds and concentrated aqueous solutions of theophylline or caffeine | |
DE1593222A1 (en) | Surface-active substances, processes for their production and their use for cosmetic purposes | |
DE667211C (en) | Process to increase the water solubility of purine bases | |
DE637792C (en) | Process for the production of durable solutions of complex lead salts | |
DE570860C (en) | Process for the production of easily soluble derivatives of pyridine derivatives | |
DE644078C (en) | Process for the preparation of a salt of 4-oxy-3-acetylaminophenyl-1-arsic acid with the toxin of iso-octylhydrocupreine (vuzinotoxin) | |
DE727685C (en) | Process for the production of concentrated diazolo solutions from solid diazonium chloride-chlorozinc double salts | |
DE686826C (en) | Process for the production of waterfast colors or prints on paper stock or finished paper | |
DE742602C (en) | Process for the preparation of aqueous solutions of theophylline | |
DE574564C (en) | Process for the preparation of salts of dibasic organic acids | |
DE964049C (en) | Process for the production of a spasmolytically effective salt of the ª ‡ -N- (ª ‰ -diaethylaminoaethyl) -aminophenylessigsaeureisoamylesters | |
DE682875C (en) | Process for the production of stable organic ferrous compounds | |
DE832754C (en) | Process for the production of aqueous solutions of poorly soluble xanthine compounds | |
DE960194C (en) | Process for the preparation of an undecylenic acid ester which is therapeutically effective against mycosis | |
DE696810C (en) | Process for the production of ascorbic acid | |
DE759064C (en) | Method of accelerating yeast fermentation |